ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Effect of the Affordable Care Act on Insurance Status, Waitlist, and Transplant Outcomes in Liver Transplantation

B. I. Shaw1, M. L. Samoylova1, V. Wang2, T. Risoli Jr3, S. Peskoe3, K. Caddell3, L. M. McElroy1

1Surgery, Duke University, Durham, NC, 2Population Health Sciences, Duke University, Durham, NC, 3Biostatistics, Duke University, Durham, NC

Meeting: 2021 American Transplant Congress

Abstract number: 114

Keywords: Kidney transplantation, Outcome

Topic: Clinical Science » Biomarkers, Immune Assessment and Clinical Outcomes

Session Information

Session Name: Biomarkers, Immune Assessment and Clinical Outcomes - II

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 6, 2021

Session Time: 4:30pm-5:30pm

 Presentation Time: 4:45pm-4:50pm

Location: Virtual

*Purpose: The Affordable Care Act (ACA) intended to expand Medicaid to cover all adults with income below 138% of federal poverty level. We describe the effect of the ACA on payor status and outcomes of liver transplant candidates.

*Methods: We conducted a retrospective cohort study of liver transplant candidates and assessed changes in payor sources and outcomes in the years before (2007-2010), during (2011-2014), and after (2015-2018) ACA implementation. For waitlist outcomes (death/delisting and transplant), multivariable competing risks models were used to estimate sub-distribution hazard ratios (SHR), with interaction terms used to assess the changing impact of insurance over time. Poisson models were used to estimate incidence rate ratios (IRR) for inactivations within the first year. For transplant outcomes, Cox proportional hazards models were used to estimate the effect of insurance status on death and graft loss over time.

*Results: In our cohort of 121,298 liver waitlisted candidates, the proportion insured by Medicaid increased over time (Table 1). Medicaid patients had higher risk of death or de-listing (SHR 1.31 95%CI 1.26-1.35, p<0.001) and lower risk of receiving transplant (SHR 0.81 95%CI 0.79-0.83, p<0.001) than those privately-insured. After 2014, the likelihood of transplant for Medicaid candidates further decreased (Figure 1). Medicaid-insured patients had a higher rate of inactivation within the first year on the waiting list than the privately insured (IRR 1.20 95%CI 1.19-1.20,p<0.001). Among those receiving liver transplant, Medicaid-insured patients had higher risk of death (HR 1.16 95% CI 1.11-1.21,p<0.001) and graft loss (HR 1.20 95%CI 1.14-1.25, p<0.001); these risks did not significantly change over time.

*Conclusions: Medicaid expansion via the ACA is associated with an increase in the number of patients listed for liver transplant, but these patients continue to have inferior waitlist and post-transplant outcomes relative to the privately insured.

Table 1. Proportion of waitlist on Medicaid, by listing state ACA expansion timing and waitlist era
Characteristic 2007-2010.(n=38,575) 2011-2014.(n=39,656) 2015-2018. (n=43,067) p-value
Initial Expansion n=20,364 n=20,803 n=22,234
Medicaid 3,625 (17.8%) 4,059 (19.5%) 5,225 (23.5%) <0.001
Later Expansion n=5,024 n=4,774 n=5,025
Medicaid 739 (14.5%) 758 (15.9%) 885 (17.6%) <0.001
No Expansion n=12,996 n=13,843 n=15,639
Medicaid 1,559 (12.0%) 1,751 (12.6%) 1,598 (10.2%) <0.001

 border=

Figure 1. Effect of Medicaid vs Private insurance on liver transplant waitlist outcomes, by era.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Shaw BI, Samoylova ML, Wang V, Jr TRisoli, Peskoe S, Caddell K, McElroy LM. The Effect of the Affordable Care Act on Insurance Status, Waitlist, and Transplant Outcomes in Liver Transplantation [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/the-effect-of-the-affordable-care-act-on-insurance-status-waitlist-and-transplant-outcomes-in-liver-transplantation/. Accessed May 16, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences